New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 27, 2012
07:31 EDTCNDOCoronado Biosciences acquires TSO manufacturing rights from Ovamed
Coronado Biosciences announced the acquisition of manufacturing rights to its lead product TSO, or Trichuris suis ova or CNDO-201, from Ovamed GmbH, for North America, South America, and Japan, Coronado's licensed territory. As part of the transaction, Coronado entered into a lease agreement to establish a manufacturing facility in Woburn, MA to produce TSO. Under the amendments, Coronado will pay Ovamed a total of $1.5M in three equal installments in 2014-2016, and, in lieu of product supply payments that would have been payable to Ovamed as the exclusive supplier, certain fees for product manufactured and sold by Coronado.
News For CNDO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2014
08:37 EDTCNDOCoronado forms subsidiary to acquire, license dermatology products
Coronado Biosciences has formed a wholly owned subsidiary, Journey Medical Corporation, or JMC, to acquire and license dermatology products. Under the leadership of Claude Maraoui, CEO, JMC will begin building a portfolio of dermatological assets focused on acne, steroid responsive dermatoses, pigmentation and antifungals for promotion to dermatologists and pediatricians.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use